127 related articles for article (PubMed ID: 14992427)
1. Transforming growth factor-beta (TGF-beta) protein levels are not elevated in the blood or bile of patients with primary sclerosing cholangitis: a pilot study.
Watt JK; Hawkins K; Zhang M; Lipschitz J; Sandha G; Gong Y; Uhanova J; Minuk GY
Dig Dis Sci; 2004 Jan; 49(1):5-8. PubMed ID: 14992427
[TBL] [Abstract][Full Text] [Related]
2. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
[TBL] [Abstract][Full Text] [Related]
4. Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
Voigtländer T; Wlecke J; Negm AA; Lenzen H; Manns MP; Lankisch TO
J Clin Gastroenterol; 2014; 48(10):866-9. PubMed ID: 24440929
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
[TBL] [Abstract][Full Text] [Related]
6. Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.
Zweers SJ; Shiryaev A; Komuta M; Vesterhus M; Hov JR; Perugorria MJ; de Waart DR; Chang JC; Tol S; Te Velde AA; de Jonge WJ; Banales JM; Roskams T; Beuers U; Karlsen TH; Jansen PL; Schaap FG
Liver Int; 2016 Sep; 36(9):1370-7. PubMed ID: 26866350
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
Tietz-Bogert PS; Kim M; Cheung A; Tabibian JH; Heimbach JK; Rosen CB; Nandakumar M; Lazaridis KN; LaRusso NF; Sung J; O'Hara SP
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332763
[TBL] [Abstract][Full Text] [Related]
8. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
9. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
10. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.
Katt J; Schwinge D; Schoknecht T; Quaas A; Sobottka I; Burandt E; Becker C; Neurath MF; Lohse AW; Herkel J; Schramm C
Hepatology; 2013 Sep; 58(3):1084-93. PubMed ID: 23564624
[TBL] [Abstract][Full Text] [Related]
11. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
Hirschfield GM; Chazouillères O; Drenth JP; Thorburn D; Harrison SA; Landis CS; Mayo MJ; Muir AJ; Trotter JF; Leeming DJ; Karsdal MA; Jaros MJ; Ling L; Kim KH; Rossi SJ; Somaratne RM; DePaoli AM; Beuers U
J Hepatol; 2019 Mar; 70(3):483-493. PubMed ID: 30414864
[TBL] [Abstract][Full Text] [Related]
12. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
14. Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.
Karrar A; Broomé U; Södergren T; Jaksch M; Bergquist A; Björnstedt M; Sumitran-Holgersson S
Gastroenterology; 2007 Apr; 132(4):1504-14. PubMed ID: 17408653
[TBL] [Abstract][Full Text] [Related]
15. Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.
Gauss A; Ehehalt R; Lehmann WD; Erben G; Weiss KH; Schaefer Y; Kloeters-Plachky P; Stiehl A; Stremmel W; Sauer P; Gotthardt DN
World J Gastroenterol; 2013 Sep; 19(33):5454-63. PubMed ID: 24023488
[TBL] [Abstract][Full Text] [Related]
16. Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis.
Kayashima A; Sujino T; Fukuhara S; Miyamoto K; Kubosawa Y; Ichikawa M; Kawasaki S; Takabayashi K; Iwasaki E; Kato M; Honda A; Kanai T; Nakamoto N
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780302
[TBL] [Abstract][Full Text] [Related]
17. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis.
Lefkowitch JH
Arch Intern Med; 1982 Jun; 142(6):1157-60. PubMed ID: 7092426
[TBL] [Abstract][Full Text] [Related]
19. S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
Reinhard L; Rupp C; Riedel HD; Ruppert T; Giese T; Flechtenmacher C; Weiss KH; Kloeters-Plachky P; Stremmel W; Schirmacher P; Sauer P; Gotthardt DN
PLoS One; 2012; 7(1):e29821. PubMed ID: 22253789
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of etanercept in the treatment of primary sclerosing cholangitis.
Epstein MP; Kaplan MM
Dig Dis Sci; 2004 Jan; 49(1):1-4. PubMed ID: 14992426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
